Software company Titian Software and the life science company Evotec have signed a three-year agreement to expand their collaboration around Titian Software’s Mosaic Sample Management Platform.
Mosaic forms part of Evotec’s plans to expand and harmonise sample management throughout the organisation, underpinning its expanding services.
Titian offers software products and consultancy services that improve the supply of samples - small molecules, reagents, DNA, proteins, antibodies, cell lines, blood, serum, tissues - to vital research processes. Titian’s sample management software, Mosaic, improves throughput, response times, cost efficiencies, error rates, and sample conservation, laying the foundation for discovery and laboratory optimisation initiatives.
The new agreement provides unlimited Mosaic software user licences to enable rapid deployment across new Evotec sites, plus streamlines access to Titian service teams, which Evotec can draw on according to business needs. In return, it allows Titian to plan and recruit for these service demands and respond agilely.
Olivier Casamitjana, VP at Evotec said: “This agreement aligns Titian as a solution provider with our plans to expand our business further, enabling easy extension of Evotec’s systems and ensuring Titian can respond dynamically to our operational needs.”
The new agreement...provides a flexible way of working to suit the evolving needs of drug discovery
- Nicholas Spurrett, CEO at Titian Software
Evotec has relied on Mosaic software for sample management and tracking for nearly 20 years. This is not the first collaboration between Evotec and Titian; projects include the co-development of ground-breaking technologies such as acoustic dispensing workflows, and recently on inter-organisational synchronisation of inventory so that Evotec can share live inventory data and live shipment updates securely with each customer. This latter capability is included in the latest release of Mosaic software, version 9.0.
Nicholas Spurrett, CEO at Titian Software, commented: “This is a significant investment by Evotec, which is a vote of confidence in the Mosaic software platform and in Titian being a trusted partner and foundation for Evotec to build on.”
Spurrett continued: “The new agreement - offering unlimited licences, pre-purchase service days for ‘support on tap,’ and new technologies underpinning our services - provides a flexible way of working to suit the evolving needs of drug discovery.”